Semaglutide Side Effects (2026): Complete Guide to Managing Them

Gastrointestinal issues are by far the most frequently reported side effects of semaglutide. Nausea affects roughly 40-45% of patients, particularly during the first few weeks and after dose increases.

Other common GI side effects include diarrhea (about 30%), vomiting (around 25%), and constipation (about 24%). These numbers can sound alarming, but context matters: most side effects are mild to moderate, and they tend to improve significantly over time as your body adjusts.

Understanding how GLP-1 medications work can help explain why these effects occur.

Most patients notice side effects within the first week of starting semaglutide or after a dose increase. The first two to four weeks on a new dose are usually when symptoms are most noticeable.

By weeks four to six at a stable dose, the majority of patients report a meaningful reduction in side effects. This is exactly why the medication uses a gradual titration schedule - starting at a low dose and increasing slowly gives your body time to adapt.

For a detailed week-by-week timeline, see our guide on your first month on medication.

Nausea is the number one complaint, but there are effective strategies to manage it. Eat smaller, more frequent meals instead of large portions.

Avoid greasy, fried, or heavily spiced foods, especially in the first few weeks. Stay well hydrated throughout the day - dehydration makes nausea worse.

Eating bland, protein-rich foods tends to be better tolerated. Some patients find that ginger tea, peppermint, or eating crackers before meals helps.

For detailed meal recommendations, read our guide on what to eat while on GLP-1 medication. If nausea is severe, your provider may recommend a slower dose titration or temporary use of anti-nausea medication.

While rare, some side effects require immediate medical attention. These include severe abdominal pain that doesn't go away (which could indicate pancreatitis), signs of gallbladder problems (intense pain in the upper right abdomen), allergic reactions (swelling of face, lips, or tongue), and changes in vision.

Semaglutide also carries a boxed warning about thyroid C-cell tumors observed in animal studies, though this has not been confirmed in humans. Patients with a personal or family history of medullary thyroid carcinoma should not use semaglutide.

Beyond avoiding greasy foods, several practical strategies can make a real difference. Eat slowly - rushing meals worsens nausea significantly when gastric emptying is slowed.

Stop eating when you feel satisfied, not full. Choose lean proteins and cooked vegetables over raw or fibrous foods in the first few weeks.

Stay upright for at least 30 minutes after eating. If constipation is an issue, increase water intake and consider a gentle fiber supplement.

For a complete nutrition framework, see our guide to eating on GLP-1 medication.

For most patients, the worst side effects occur during the first 2-4 weeks on a new dose and then gradually improve. By the time you've been on a stable dose for 4-6 weeks, most GI symptoms are significantly reduced or gone entirely.

The gradual titration schedule (starting low, increasing monthly) is specifically designed to minimize this adjustment period. Some patients experience almost no side effects, while others need a slower titration.

Your provider can customize the schedule based on your response. See our semaglutide timeline for week-by-week expectations.

Both semaglutide and tirzepatide share similar GI side effect profiles. In head-to-head comparisons, tirzepatide may have slightly higher rates of certain symptoms at its maximum dose (15 mg), but at comparable doses, tolerability is similar.

The choice between them should be based on effectiveness and cost rather than side effects alone. For a full comparison, see our Mounjaro vs Ozempic guide.

Having a qualified medical provider monitor your treatment is essential, not optional. Your provider can adjust your dosing schedule, recommend strategies for managing side effects, and identify any concerning symptoms early.

This is one of the most important factors when choosing a telehealth weight loss provider - make sure the platform includes ongoing medical oversight, not just an initial prescription. Regular check-ins, easy access to your care team, and responsive support can make the difference between a rough experience and a manageable one. Compare providers that prioritize clinical support.

For most patients, side effects are temporary and manageable. Clinical trial dropout rates due to side effects were relatively low (5-8%), meaning the vast majority of patients found the benefits outweighed the discomfort.

The key is starting with realistic expectations, having a good provider, and using the management strategies above. If you're unsure whether semaglutide is right for you, check our eligibility guide or take our matching quiz to find a provider who can evaluate your specific situation.